Open Access Email this article to a friend

Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

Marie Hudson*, Janet Pope, Michael Mahler, Solène Tatibouet, Russell Steele, Murray Baron, Canadian Scleroderma Research Group (CSRG) and Marvin J Fritzler

Arthritis Research & Therapy 2012, 14:R50 doi:10.1186/ar3763

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive Arthritis Research & Therapy's emails?